Filing Details

Accession Number:
0001209191-17-053024
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-15 17:12:15
Reporting Period:
2017-08-28
Accepted Time:
2017-09-15 17:12:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419600 Flexion Therapeutics Inc FLXN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1703032 Yamo Deniz C/O Flexion Therapeutics, Inc.
10 Mall Road, Suite 301
Burlington MA 01803
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-31 1,375 $25.40 5,000 No 4 P Direct
Common Stock Acquisiton 2017-09-01 1,000 $24.55 6,000 No 4 P Direct
Common Stock Acquisiton 2017-09-01 2,000 $23.95 8,000 No 4 P Direct
Common Stock Acquisiton 2017-09-05 1,000 $24.20 9,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Call Option (right to buy) Acquisiton 2017-08-28 20 $2.90 2,000 $30.00
Common Stock Call Option (right to buy) Acquisiton 2017-09-05 10 $5.50 1,000 $22.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20 2017-08-28 2017-10-20 No 4 P Direct
10 2017-09-05 2017-11-17 No 4 P Direct